JP2025513894A5 - - Google Patents
Info
- Publication number
- JP2025513894A5 JP2025513894A5 JP2024560753A JP2024560753A JP2025513894A5 JP 2025513894 A5 JP2025513894 A5 JP 2025513894A5 JP 2024560753 A JP2024560753 A JP 2024560753A JP 2024560753 A JP2024560753 A JP 2024560753A JP 2025513894 A5 JP2025513894 A5 JP 2025513894A5
- Authority
- JP
- Japan
- Prior art keywords
- tapi
- cell
- polynucleotide
- cancer
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331773P | 2022-04-15 | 2022-04-15 | |
| US63/331,773 | 2022-04-15 | ||
| PCT/US2023/065784 WO2023201340A2 (en) | 2022-04-15 | 2023-04-14 | Compositions and methods for reducing cell therapy immunogenicity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513894A JP2025513894A (ja) | 2025-04-30 |
| JP2025513894A5 true JP2025513894A5 (cg-RX-API-DMAC7.html) | 2026-04-22 |
Family
ID=88330399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560753A Pending JP2025513894A (ja) | 2022-04-15 | 2023-04-14 | 細胞療法の免疫原性を低下させるための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250325585A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4508197A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513894A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023254114A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249063A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023201340A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2752933C2 (ru) * | 2014-03-11 | 2021-08-11 | Селлектис | Способ создания т-клеток, пригодных для аллогенной трансплантации |
| WO2020018708A1 (en) * | 2018-07-18 | 2020-01-23 | The General Hospital Corporation | Compositions and methods for treatment of t cell malignancies |
| CA3106980A1 (en) * | 2018-07-22 | 2020-01-30 | Health Research, Inc. | Major histocompatibility complex class ll-expressing cancer cell vaccine and methods of use for producing integrated immune responses |
| EP4150058A4 (en) * | 2020-05-13 | 2024-06-19 | Nanjing Legend Biotech Co., Ltd. | COMPOSITIONS AND METHODS FOR REDUCING HOST REJECTION OF ALLOGENIC CELLS USING MONKEY ICP47 AND VARIANTS THEREOF |
-
2023
- 2023-04-14 WO PCT/US2023/065784 patent/WO2023201340A2/en not_active Ceased
- 2023-04-14 US US18/856,592 patent/US20250325585A1/en active Pending
- 2023-04-14 EP EP23789180.9A patent/EP4508197A4/en active Pending
- 2023-04-14 CA CA3249063A patent/CA3249063A1/en active Pending
- 2023-04-14 JP JP2024560753A patent/JP2025513894A/ja active Pending
- 2023-04-14 AU AU2023254114A patent/AU2023254114A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109485734B (zh) | 一种靶向bcma和cd19的双特异性嵌合抗原受体及其应用 | |
| JP2021000103A5 (cg-RX-API-DMAC7.html) | ||
| JP2021520788A5 (cg-RX-API-DMAC7.html) | ||
| AU2023201162A1 (en) | Compositions and methods for immunooncology | |
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2018527014A5 (cg-RX-API-DMAC7.html) | ||
| EP3116902B1 (en) | Method for generating t-cells compatible for allogenic transplantation | |
| US20220348929A1 (en) | Crispr abasic restricted nucleotides and crispr accuracy via analogs | |
| WO2021163618A1 (en) | Method of predicting response to chimeric antigen receptor therapy | |
| RU2017105065A (ru) | Лечение злокачественного новообразования с использованием гуманизированного химерного антигенного рецептора против всма | |
| RU2017108903A (ru) | Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей | |
| JP2019515661A5 (cg-RX-API-DMAC7.html) | ||
| JP2017522879A5 (cg-RX-API-DMAC7.html) | ||
| JP2017527271A5 (cg-RX-API-DMAC7.html) | ||
| RU2017105161A (ru) | Лечение рака с использованием химерного антигенного рецептора cll-1 | |
| JP2022512882A5 (cg-RX-API-DMAC7.html) | ||
| JP2022530773A5 (cg-RX-API-DMAC7.html) | ||
| JP2021530233A5 (cg-RX-API-DMAC7.html) | ||
| RU2019128921A (ru) | Антитело к il-13ra2 и его применение | |
| EP3508504A1 (en) | Human-cd123-targeting chimeric receptor ligand and application thereof | |
| EP4055049A1 (en) | Bcma-targeted car-t cell therapy of multiple myeloma | |
| JP2022538425A5 (cg-RX-API-DMAC7.html) | ||
| JP2020500903A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518930A5 (cg-RX-API-DMAC7.html) | ||
| CN118221828B (zh) | Car分子、car细胞和car药物组合物及其应用 |